Private equity firm The Carlyle Group has agreed to purchase the management contracts on USD5.1bn in collateralised loan obligations and other credit assets from Stanfield Capital Partners, a fixed income asset manager based in New York. The transaction, part of a broader strategy to expand the scope and depth of

Grant Thornton has produced a white paper offering a number of suggestions for healthcare organisations to assist them in restoring rigor and discipline throughout their businesses. With the uncertainty surrounding healthcare reform, the effects of a slow-to-recover economy, and the constraints of tight credit markets, the healthcare industry is facing

J.P. Morgan Worldwide Securities Services has signed an agreement to acquire the private equity administration services business of Schroders, subject to regulatory approval. Based in Guernsey and Bermuda, the private equity administration services business currently has USD6.2bn in committed capital under administration. "This acquisition emphasises our commitment to continuing to

Maranon Capital has provided senior and mezzanine debt as well, as an equity co-investment in partnership with Gridiron Capital and management, to support an investment in TharpeRobbins. The transaction is Maranon’s seventh investment overall and its second one-stop financing. TharpeRobbins was formed in 2007 through the merger of The Tharpe

Ludgate Environmental Fund has invested GBP730,000 into 10,000,000 ordinary shares of Hightex Group, equivalent to 5.3 per cent of its issued share capital. Hightex is one of only two companies operating internationally to design and install large area membrane roofs and façades. It uses environmentally friendly materials and innovative coatings

Deutsche Börse’s IPO indicator for quarter two 2010 shows that sentiment concerning initial public offerings on the German equities market is increasingly positive. Falling volatility on equity markets combined with increasing share prices indicates heightened issuing activity. Parallel to this, market participants’ expectations concerning IPOs have continued to improve. Market

In the first quarter of 2010 venture capitalists from around the world invested USD7bn in 919 deals for companies based in the US, Europe, Canada, Israel, mainland China and India, according to Dow Jones VentureSource. This is a 13 per cent increase over the USD6.2bn invested in 860 deals during

Venture capital funding in the life sciences sector, which includes the biotechnology and medical device industries, captured the highest percentage of venture capital dollars invested during the first quarter of 2010, according to a report by PricewaterhouseCoopers. The report, based on data from Thomson Reuters, shows that life sciences funding